Some patients that we have worked with in the past shared with us that they had been eating significantly larger portions of their meals prior to taking the weight loss injections semaglutide or tirzepatide and thought they needed to continue eating the same amount of food to fuel their body, even though the medication suppressed their hunger and they felt fuller for a significantly longer period of time
This bimodal distribution, heavily skewed toward extreme dissatisfaction, is a classic marker of a company with significant operational problems
GLP-1 medications are contraindicated for those with personal or family history of medullary thyroid cancer
There are now 2,809 active lawsuits against Eli Lilly and other GLP-1 manufacturers
Willow is transforming how weight loss works by combining medical-grade treatment, cutting-edge GLP-1 medications, and hands-on virtual care
Expertise in Liposomal Supplement Formulations With specialized R&D teams focused on liposomal technologies, Eskag Pharma offers scientifically backed formulations that maximize bioavailability and therapeutic effects